|
Volumn 33, Issue 1 SUPPL. 1, 1996, Pages 45-52
|
Treatment of multiple sclerosis and other autoimmune diseases with cladribine
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CLADRIBINE;
HEMOGLOBIN;
PLACEBO;
AUTOIMMUNE HEMOLYTIC ANEMIA;
AUTOIMMUNITY;
BONE MARROW SUPPRESSION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG THERAPY;
HUMAN;
INFECTION;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKOCYTE COUNT;
LYMPHOCYTE COUNT;
MEAN CORPUSCULAR VOLUME;
MULTIPLE SCLEROSIS;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SUBCUTANEOUS DRUG ADMINISTRATION;
THROMBOCYTE COUNT;
THROMBOCYTOPENIC PURPURA;
ANALYSIS OF VARIANCE;
AUTOIMMUNE DISEASES;
CLADRIBINE;
CROSS-OVER STUDIES;
DOUBLE-BLIND METHOD;
FOLLOW-UP STUDIES;
HEMATOLOGIC TESTS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MAGNETIC RESONANCE IMAGING;
MULTIPLE SCLEROSIS;
NEUROLOGIC EXAMINATION;
PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;
|
EID: 0030029730
PISSN: 00371963
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (40)
|
References (0)
|